Proto-Oncogene Proteins c-mos
"Proto-Oncogene Proteins c-mos" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Cellular proteins encoded by the c-mos genes (GENES, MOS). They function in the cell cycle to maintain MATURATION PROMOTING FACTOR in the active state and have protein-serine/threonine kinase activity. Oncogenic transformation can take place when c-mos proteins are expressed at the wrong time.
| Descriptor ID |
D017231
|
| MeSH Number(s) |
D08.811.913.696.620.682.700.559.800 D12.644.360.400.800 D12.776.476.400.800 D12.776.624.664.700.187
|
| Concept/Terms |
Proto-Oncogene Proteins c-mos- Proto-Oncogene Proteins c-mos
- Proteins c-mos, Proto-Oncogene
- Proto Oncogene Proteins c mos
- c-mos, Proto-Oncogene Proteins
- Proto-Oncogene Products c-mos
- Products c-mos, Proto-Oncogene
- Proto Oncogene Products c mos
- c-mos, Proto-Oncogene Products
- Proto-Oncogene Proteins mos
- Proteins mos, Proto-Oncogene
- Proto Oncogene Proteins mos
- pp39(c-mos)
- mos Proto-Oncogene Product pp39
- mos Proto Oncogene Product pp39
- Cytostatic Factor
- pp39 c-mos
- c-mos, pp39
- pp39 c mos
- c-mos Proteins
- Proteins, c-mos
- c mos Proteins
- mos Proto-Oncogene Proteins
- Proteins, mos Proto-Oncogene
- Proto-Oncogene Proteins, mos
- mos Proto Oncogene Proteins
|
Below are MeSH descriptors whose meaning is more general than "Proto-Oncogene Proteins c-mos".
Below are MeSH descriptors whose meaning is more specific than "Proto-Oncogene Proteins c-mos".
This graph shows the total number of publications written about "Proto-Oncogene Proteins c-mos" by people in this website by year, and whether "Proto-Oncogene Proteins c-mos" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2002 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Proto-Oncogene Proteins c-mos" by people in Profiles.
-
Phenotypic effects of knockout of oocyte-specific genes. Ernst Schering Res Found Workshop. 2002; (41):63-79.
-
Evidence for an important role of serine 16 and its phosphorylation in the stabilization of c-Mos. Oncogene. 1999 Jul 29; 18(30):4287-94.
-
Evidence of an interaction between Mos and Hsp70: a role of the Mos residue serine 3 in mediating Hsp70 association. Oncogene. 1999 Jun 10; 18(23):3461-70.
-
Paclitaxel-induced apoptosis is associated with expression and activation of c-Mos gene product in human ovarian carcinoma SKOV3 cells. Cancer Res. 1998 Aug 15; 58(16):3633-40.
-
Evidence of a functional interaction between serine 3 and serine 25 Mos phosphorylation sites. A dominant inhibitory role of serine 25 phosphorylation on Mos protein kinase. J Biol Chem. 1998 Jun 26; 273(26):15946-53.
-
Elevated level of cyclin D1 in mos-transformed cells. Int J Oncol. 1998 May; 12(5):1199-202.
-
Mos and the cell cycle. Prog Cell Cycle Res. 1997; 3:251-9.
-
Further characterization of the c-mos transcript and its cell cycle specific expression in NIH3T3 cells. Oncogene. 1996 Apr 04; 12(7):1571-6.
-
Excess early signaling activity inhibits cellular chemotaxis toward PDGF-BB. Oncogene. 1994 May; 9(5):1429-35.
-
Calmodulin-dependent protein kinase II mediates inactivation of MPF and CSF upon fertilization of Xenopus eggs. Nature. 1993 Nov 18; 366(6452):270-3.